Financial Survey: Moolec Science (NASDAQ:MLEC) versus Fifth Wall Acquisition Corp. III (NASDAQ:FWAC)

Moolec Science (NASDAQ:MLEC) and Fifth Wall Acquisition Corp. III (NASDAQ:FWAC) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Insider & Institutional Ownership

0.1% of Moolec Science shares are held by institutional investors. Comparatively, 94.7% of Fifth Wall Acquisition Corp. III shares are held by institutional investors. 19.9% of Moolec Science shares are held by insiders. Comparatively, 22.1% of Fifth Wall Acquisition Corp. III shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

Moolec Science has a beta of -0.54, suggesting that its stock price is 154% less volatile than the S&P 500. Comparatively, Fifth Wall Acquisition Corp. III has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Moolec Science and Fifth Wall Acquisition Corp. III, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	3	0	3.00
Fifth Wall Acquisition Corp. III	0	0	0	0	N/A

Moolec Science presently has a consensus target price of $5.50, suggesting a potential upside of 483.86%. Given Moolec Science’s higher probable upside, equities research analysts plainly believe Moolec Science is more favorable than Fifth Wall Acquisition Corp. III.

Valuation and Earnings

This table compares Moolec Science and Fifth Wall Acquisition Corp. III’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$5.01 million	7.07	-$51.79 million	N/A	N/A
Fifth Wall Acquisition Corp. III	N/A	N/A	$280,000.00	N/A	N/A

Fifth Wall Acquisition Corp. III has lower revenue, but higher earnings than Moolec Science.

Profitability

This table compares Moolec Science and Fifth Wall Acquisition Corp. III’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-150.27%	-87.89%	-33.26%
Fifth Wall Acquisition Corp. III	N/A	-81.59%	1.89%

Summary

Fifth Wall Acquisition Corp. III beats Moolec Science on 7 of the 10 factors compared between the two stocks.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

About Fifth Wall Acquisition Corp. III

Fifth Wall Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire business in the real estate industry. The company was incorporated in 2021 and is based in New York, New York.